Clinical Trial

Effect of CoQ10 on the Endocrine Function of Skeletal Muscle

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 4, 2023 (before its estimated July 31, 2023 completion). Its status may not reflect the trial's current state.
Summary
Recent studies have also shown that repeated episodes of ischemia, followed by reperfusion (IPC), can contribute to the development of adaptive changes not only in the area of the heart muscle, but also in the structure of the skeletal muscles. In the project, several research questions will be evaluated e.g. what is the relationship between oxidative stress parameters, uric acid concentration and nitric oxide degradation products in groups of people undergoing two-week training in ischemic training, or what is the relationship between the expression of genes associated with muscle cell growth (e.g. myostatin gene) and the effect of ischemia preconditioning training etc.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-06-07.
Trial Details
NCT Number NCT05412888
Lead Sponsor Medical University of Gdansk
Conditions Ischemic Preconditioning, Coenzyme Q Deficiency, Exercise Training
Enrollment 100 participants
Start Date 2023-03-01
Primary Completion 2023-07-31 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2023-01-04